Antifungal Resistance Pattern of Candida Species Isolated from High Vaginal Swabs of Women Attending a Hospital in Enugu State, Nigeria
Joachim Ohiakwu Ezeadila, Ikechukwu Okoli, Christie Amaechi Oyeka
Journal of Advances in Microbiology · pp. 62–72 · Published 9 Oct 2020
10.9734/jamb/2020/v20i930281Abstract
There is an increase in non-albicans Candida (NAC) vulvovaginal candidiasis which is attributed to overuse of antifungal therapy and this has led to antifungal resistance. This study was aimed at determining the antifungal resistance pattern of some clinical isolates of Candida species. Eighty-eight (88) isolates were used which included Candida tropicalis (34), Candida Parapsilosis (21), Candida albicans (20), Candida krusei (7) and Candida glabrata (6). The drugs used were Fluconazole (25µg), Ketoconazole (10µg), Voriconazole (1µg), Nystatin (100Units), Amphotericin B (20µg), Flucytosine (1µg), Clotrimazole (10µg) and Itraconazole (50µg). The susceptibility testing was carried out using the M44-A standard method for yeast disk diffusion testing. Results showed that the percentages of Candida species resistant to Fluconazole, Ketoconazole, Voriconazole, Amphotericin B, Flucytosine, Clotrimazole and Itraconazole and Nystatin were 52.3%, 61.9%, 35.2%, 19.3%, 86.4%, 34.1%, 45.5% and 44.3%, with inhibition zone diameters ≤14mm, ≤20mm, ≤13mm, <10mm, ≤11mm, ≤11mm, ≤13mm and no inhibition zone diameter respectively. Candida krusei was the most resistant species with 100% resistance to each of Fluconazole, Ketoconazole and Flucytosine. Candida tropicalis was the species with the highest susceptibility (79.4%) to Amphotericin B followed by Candida parapsilosis with inhibition zone diameters ≥15mm. While Candida glabrata showed 100% resistance to each of Flucytosine and Itraconazole, Candida albicans showed 100% resistance to Flucytosine only. Candida glabrata was the only Candida species with 0% resistance to Amphotericin B. The drug to which most of the Candida species were susceptible was Amphotericin B followed by Voriconazole while Flucytosine was the drug with the highest resistance followed by Ketoconazole and Fluconazole. The highest number of susceptible-dose dependent Candida isolates was observed with Ketoconazole (25%), followed by Clotrimazole and Itraconazole, each recording 23.9%. Based on the findings of the present study, Voriconazole is recommended for vaginal candidiasis especially in the study area and also especially for infections caused by Fluconazole-resistant Candida species. This suggests that routine sensitivity testing is pertinent to guiding the choice of antifungal therapy. Thus, indiscriminate use of antifungal drugs should be avoided to reduce the development and spread of resistance.
References (16)
- 1 Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion [DOI]
- 2 Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline
- 3 Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment [DOI]
- 4 Yeast ATP-Binding Cassette Transporters Conferring Multidrug Resistance [DOI]
- 5 Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern [DOI]
- 6 The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: A mycological perspective [DOI]
- 7 Epidemiology and antifungal resistance in invasive candidiasis [DOI]
- 8 Antifungal drug resistance in Candida species [DOI]
- 9 Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia [DOI]
- 10 In Vitro Susceptibility of Candida Species to Four Antifungal Agents Assessed by the Reference Broth Microdilution Method [DOI]
- 11 In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia [DOI]
- 12 Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage [DOI]
- 13 Comparison Between Virulence Factors of Candida albicans and Non-Albicans Species of Candida Isolated from Genitourinary Tract [DOI]
- 14 Candidaspp.in vitrosusceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains [DOI]
- 15 Microsatellite analysis of Candida isolates from recurrent vulvovaginal candidiasis [DOI]
- 16 Exoenzymes Production and Antifungal Susceptibility of Candida Species Isolated from Pregnant Women with Vulvovaginitis
Cited by 8
J. C. Adindu, C. O. Anyamene, C. U. Ezebialu, D. C. Chukwukaelo, C. F. Chude, L. E. Eruala, A. Umeofor · Journal of Advances in Microbiology · 2023
Akshay Kisan Mundhe, Reena Rajkumari · Frontiers in Cellular and Infection Microbiology · 2025
Vidyavathi B Chitharagi, Johanna N Sem, Raghavendra Rao Morubagal · IP International Journal of Medical Microbiology and Tropical Diseases · 2024
Showing 3 of 8 known citations — external sources report more than can currently be individually listed.
Related research
- Knowledge, Attitude and Predisposing Risk Factors of Non-Albican Vulvovaginal Candidiasis among Symptomatic Women in Port Harcourt — shares topic coverage
- Antifungal Susceptibility Patterns of Vulvovaginal Candida species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda — shares topic coverage
- Prevalence and Antifungal Susceptibility patterns of Candida Isolated on CHROMagarTMCandida at a Tertiary Referral Hospital, Eastern Uganda — shares topic coverage
- A Hospital-based Study on the Detection of Fluconazole-resistant Candida albicans from Women with Vulvovaginal Candidiasis in Port Harcourt — shares topic coverage
- Correlates of Vulvovaginal Candidiasis among Attendees of a Special Treatment Clinic in Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
85
Page views
0
PDF downloads
21
Outbound clicks
8
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.